298
Views
3
CrossRef citations to date
0
Altmetric
Articles

Using a game-theoretic approach to design optimal health insurance for chronic disease

, &

References

  • Alagoz, O., Maillart, L. M., Schaefer, A. J., and Roberts, M. S. (2004) The optimal timing of living-donor liver transplantation. Management Science, 50, 1420–1430.
  • Arrow, K. J. (1963) Uncertainty and the welfare economics of medical care. The American Economic Review, 53, 941–973.
  • Arrow, K. J. (1976) Welfare analysis of changes in health coinsurance rates. In The Role of Health Insurance in the Health Services Sector (pp. 1–34). NBER, New York, NY.
  • Betancourt, J. R., Green, A. R., Carrillo, J. E., et al. (2002) Cultural Competence in Health Care: Emerging Frameworks and Practical Approaches, volume 576. Commonwealth Fund, Quality of Care for Underserved Populations, New York, NY.
  • Briesacher, B. A., Gurwitz, J. H., and Soumerai, S. B. (2007) Patients at-risk for cost-related medication nonadherence: A review of the literature. Journal of General Internal Medicine, 22, 864–871.
  • Brook, R. H., Ware, J. E., Rogers, W. H., Keeler, E. B., Davies, A. R., Sherbourne, C. D., Goldberg, G. A., Lohr, K., Camp, P., and Newhouse, J. P. (1984) The effect of coinsurance on the health of adults: Results from the RAND Health Insurance Experiment, Report R-3055-HHS, Santa Monica, CA.
  • Brunström, M., and Carlberg, B. (2016) Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: Systematic review and meta-analyses. British Medical Journal, 352, i717.
  • Cardiovascular Business. (2017) Treating uncontrolled hypertension makes dollars and sense. http://www.cardiovascularbusiness.com/topics/healthcare-economics/treating-uncontrolled-hypertension-makes-dollars-and-sense (accessed August 28, 2017).
  • Centers for Disease Control and Prevention (CDC). (2012) Vital signs: Awareness and treatment of uncontrolled hypertension among adults–United States, 2003-2010. Morbidity and Mortality Weekly Report, 61, 703.
  • Centers for Disease Control and Prevention (CDC). (2015) High blood pressure facts. http://www.cdc.gov/bloodpressure/facts.htm/ (accessed August 28, 2017).
  • Chang, T.-S., and Ho, Y.-C. (1981) Incentive problems: A class of stochastic stackelberg closed-loop dynamic games. Systems & Control Letters, 1, 16–21.
  • Chang, T.-S., and Ho, Y.-C. (1983) Stochastic Stackelberg games: Nonnested multistage multiagent incentive problems. IEEE Transactions on Automatic Control, 28, 477–488.
  • Chao, L.-W. (2002) A comparison of consensus and nonconsensus approaches to modeling contraceptive choice behavior. Health Economics, 11, 599–622.
  • Chen, B., and Fan, V. Y. (2015) Strategic provider behavior under global budget payment with price adjustment in Taiwan. Health Economics, 24, 1422–1436.
  • Chernew, M. E., Rosen, A. B., and Fendrick, A. M. (2007) Value-based insurance design. Health Aff (Millwood), 26, w195–w203.
  • Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., Roccella, E. J., and the National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 42, 1206–1252.
  • Christian-Herman, J., Emons, M., and George, D. (2004) Effects of generic-only drug coverage in a Medicare HMO. Health Affairs, 23, W4.
  • Conitzer, V., and Sandholm, T. (2006) Computing the optimal strategy to commit to. In Proceedings of the 7th ACM Conference on Electronic Commerce, 82–90.
  • CostHelper (2017) High blood pressure treatment cost. http://health.costhelper.com/treating-high-blood-pressure-cost.html (accessed August 28, 2017).
  • Cutler, D. M., and Zeckhauser, R. J. (2000) The anatomy of health insurance. Handbook of Health Economics, 1, 563–643.
  • Delle Fave, F. M., Jiang, A. X., Yin, Z., Zhang, C., Tambe, M., Kraus, S., and Sullivan, J. P. (2014) Game-theoretic patrolling with dynamic execution uncertainty and a case study on a real transit system. Journal of Artificial Intelligence Research, 50, 321–367.
  • Doiron, D., Jones, G., and Savage, E. (2008) Healthy, wealthy and insured? The role of self-assessed health in the demand for private health insurance. Health Economics, 17, 317–334.
  • Eaddy, M. T., Cook, C. L., O’Day, K., Burch, S. P., and Cantrell, C. R. (2012) How patient cost-sharing trends affect adherence and outcomes: A literature review. Pharmacy and Therapeutics, 37, 45.
  • Elliott, W. J. (2003) The economic impact of hypertension. The Journal of Clinical Hypertension (Greenwich), 5, 3–13.
  • Ellis, R. P., Jiang, S., and Manning, W. G. (2015) Optimal health insurance for multiple goods and time periods. Journal of Health Economics, 41, 89–106.
  • Ellis, R. P., and Manning, W. G. (2007) Optimal health insurance for prevention and treatment. Journal of Health Economics, 26, 1128–1150.
  • Emanuel, E. J., and Fuchs, V. R. (2008) The perfect storm of overutilization. Journal of the American Medical Association, 299, 2789–2791.
  • Epstein, B. J. (2010) Improving blood pressure control rates by optimizing combination antihypertensive therapy. Expert Opinion on Pharmacotherapy, 11, 2011–2026.
  • Fishman, P. A., Ding, V., Hubbard, R., Ludman, E. J., Pabiniak, C., Stewart, C., Morales, L., and Simon, G. E. (2012) Impact of deductibles on initiation and continuation of psychotherapy for treatment of depression. Health Services Research, 47, 1561–1579.
  • Ganzfried, S., and Sandholm, T. (2010) Computing equilibria by incorporating qualitative models? In Proceedings of the 9th International Conference on Autonomous Agents and Multiagent Systems: Volume 1, 183–190.
  • Goldman, D., and Philipson, T. (2007) Integrated Insurance Design in the Presence of Multiple Medical Technologies. American Economic Review, 97, 427–432.
  • Goldman, D. P., Joyce, G. F., and Zheng, Y. (2007) Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. Journal of the American Medical Association, 298, 61–69.
  • Goodell, S., and Swartz, K. (2010) Cost-sharing: Effects on spending and outcomes. Policy Brief, 20, 42–45.
  • Hoadley, J. (2005) Cost Containment Strategies for Prescription Drugs: Assessing the Evidence in the Literature. Henry H. Kaiser Family Foundation, Menlo Park, CA.
  • Hu, C., Lovejoy, W. S., and Shafer, S. L. (1996) Comparison of some suboptimal control policies in medical drug therapy. Operations Research, 44, 696–709.
  • Huskamp, H. A., Deverka, P. A., Epstein, A. M., Epstein, R. S., McGuigan, K. A., and Frank, R. G. (2003) The effect of incentive-based formularies on prescription-drug utilization and spending. New England Journal of Medicine, 349, 2224–2232.
  • Huskamp, H. A., Deverka, P. A., Epstein, A. M., Epstein, R. S., McGuigan, K. A., Muriel, A. C., and Frank, R. G. (2005) Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Archives of General Psychiatry, 62, 435–441.
  • Joffres, M., Falaschetti, E., Gillespie, C., Robitaille, C., Loustalot, F., Poulter, N., McAlister, F. A., Johansen, H., Baclic, O., and Campbell, N. (2013) Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: A cross-sectional study. British Medical Journal, 3, e003423.
  • Lakić, D., Petrova, G., Bogavac-Stanojević, N., Jelić-Ivanović, Z., and Kos, M. (2012) The cost-effectiveness of hypertension pharmacotherapy in Serbia: A Markov model. Biotechnology & Biotechnological Equipment, 26, 3066–3072.
  • Lee, C. P., Chertow, G. M., and Zenios, S. A. (2008) Optimal initiation and management of dialysis therapy. Operations Research, 56, 1428–1449.
  • Lefévre, C. (1981) Optimal control of a birth and death epidemic process. Operations Research, 29, 971–982.
  • Letchford, J., MacDermed, L., Conitzer, V., Parr, R., and Isbell, C. L. (2012) Computing optimal strategies to commit to in stochastic games. In Processing of Twenty-Sixth National Conference on Artificial Intelligence, Toronto, ON, Canada.
  • Liu, X., Nestic, D., and Vukina, T. (2012) Estimating adverse selection and moral hazard effects with hospital invoices data in a government-controlled healthcare system. Health Economics, 21, 883–901.
  • Lovibond, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, F. R., Hodgkinson, J., Mant, J., Martin, U., Williams, B.,Wonderling, D., and McManus, R. J. (2011) Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study. The Lancet, 378, 1219–1230.
  • Ma, C. Y., Yau, D. K., Lou, X., and Rao, N. S. (2013) Markov game analysis for attack-defense of power networks under possible misinformation. IEEE Transactions on Power Systems, 28, 1676–1686.
  • Mann, B. S., Barnieh, L., Tang, K., Campbell, D. J., Clement, F., Hemmelgarn, B., Tonelli, M., Lorenzetti, D., and Manns, B. J. (2014) Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: A systematic review. PLoS One, 9, e89168.
  • McCormick, G. P. (1976) Computability of global solutions to factorable nonconvex programs: Part I – Convex underestimating problems. Mathematical Programming, 10, 147–175.
  • Mojtabai, R., and Olfson, M. (2003) Medication costs, adherence, and health outcomes among medicare beneficiaries. Health Affairs, 22, 220–229.
  • Moran, A. E., Odden, M. C., Thanataveerat, A., Tzong, K. Y., Rasmussen, P. W., Guzman, D., Williams, L., Bibbins-Domingo, K., Coxson, P. G., and Goldman, L. (2015) Cost-effectiveness of hypertension therapy according to 2014 guidelines. New England Journal of Medicine, 372, 447–455.
  • National Center for Health Statistics (US) (2016) Health, United States, 2015: With special feature on racial and ethnic health disparities. http://www.cdc.gov/nchs/data/hus/hus15.pdf (accessed May 7, 2018).
  • Nguyen, C. V. (2012) The impact of voluntary health insurance on health care utilization and out-of-pocket payments: New evidence for Vietnam. Health Economics, 21, 946–966.
  • Nisan, N., Roughgarden, T., Tardos, E., and Vazirani, V. V. (2007) Algorithmic Game Theory volume 1. Cambridge University Press, Cambridge, England.
  • Ostchega, Y., Yoon, S. S., Hughes, J., and Louis, T. (2008). Hypertension awareness, treatment, and control–Continued disparities in adults: United States, 2005-2006. NCHS Data Brief, 1–8.
  • Pauly, M. V., and Blavin, F. E. (2008) Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance. Journal of Health Economics, 27, 1407–1417.
  • Pita, J., Jain, M., Ordónez, F., Portway, C., Tambe, M., Western, C., Paruchuri, P., and Kraus, S. (2009) Using game theory for Los Angeles airport security. AI Magazine, 30, 43.
  • Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet, 360, 1903–1913.
  • Puterman, M. L. (2014) Markov Decision Processes: Discrete Stochastic Dynamic Programming. John Wiley & Sons, Hoboken, NJ.
  • Rothschild, M., and Stiglitz, J. (1976) Equilibrium in competitive insurance markets: An essay on the economics of imperfect information. Quarterly Journal of Economic, 90, 629–649.
  • Schaefer, A. J., Bailey, M. D., Shechter, S. M., and Roberts, M. S. (2005) Modeling medical treatment using Markov decision processes. In Operations Research and Health Care: A Handbook of Methods and Applications (pp. 593–612). Kluwer Academic Publishers, Boston, MA.
  • Shechter, S. M., Bailey, M. D., Schaefer, A. J., and Roberts, M. S. (2008) The optimal time to initiate HIV therapy under ordered health states. Operations Research, 56, 20–33.
  • Shrank, W. H., Hoang, T., Ettner, S. L., Glassman, P. A., Nair, K., DeLapp, D., Dirstine, J., Avorn, J., and Asch, S. M. (2006) The implications of choice: Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Archives of Internal Medicine, 166, 332–337.
  • Shrank, W. H., Young, H. N., Ettner, S. L., Glassman, P., Asch, S. M., and Kravitz, R. L. (2005) Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. American Journal of Managed Care, 11, 16–22.
  • Sinnott, S.-J., Buckley, C., David, O., Bradley, C., Whelton, H.(2013) The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations: A systematic review and meta-analysis. PLoS One, 8, e64914.
  • Sonnenberg, F. A., and Beck, J. R. (1993) Markov models in medical decision making: A practical guide. Medical Decision Making, 13, 322–338.
  • Steimle, L. N., and Denton, B. T. (2017) Markov decision processes for screening and treatment of chronic diseases. In Markov Decision Processes in Practice (pp. 189–222). Springer, New York, NY.
  • Su, X., and Zenios, S. (2004) Patient choice in kidney allocation: The role of the queueing discipline. Manufacturing & Service Operations Management, 6, 280–301.
  • Taira, D. A., Wong, K. S., Frech-Tamas, F., and Chung, R. S. (2006) Copayment level and compliance with antihypertensive medication: Analysis and policy implications for managed care. American Journal of Managed Care, 12, 678–684.
  • Thomas, C. P. (2008) How Prescription Drug Use Affects Health Care Utilization and Spending by Older Americans: A Review of the Literature. Public Policy Institute, Waltham, MA.
  • Ugajin, T., Hozawa, A., Ohkubo, T., Asayama, K., Kikuya, M., Obara, T., Metoki, H., Hoshi, H., Hashimoto, J., Totsune, K., Satoh, H., Tsuji, I., and Imai, Y. (2005) White-coat hypertension as a risk factor for the development of home hypertension: The Ohasama study. Archives of Internal Medicine, 165, 1541–1546.
  • US Census Bureau (2016) Selected characteristics of people 15 years and over, by total money income, work experience, race, Hispanic origin, and sex. http://www.census.gov/data/tables/time-series/demo/income-poverty/cps-pinc/pinc-01.html/ (accessed August 28, 2017).
  • Vasudeva, E., Moise, N., Huang, C., Mason, A., Penko, J., Goldman, L., Coxson, P. G., Bibbins-Domingo, K., and Moran, A. E. (2016) Comparative cost-effectiveness of hypertension treatment in non-Hispanic Blacks and Whites according to 2014 guidelines: A modeling study. American Journal of Hypertension, 29, 1195–1205.
  • Vorobeychik, Y., and Singh, S. P. (2012) Computing Stackelberg equilibria in discounted stochastic games. In Processing of Twenty-Sixth National Conference on Artificial Intelligence. Toronto, ON, Canada.
  • Wagner, S., Toftegaard, T. S., and Bertelsen, O. W. (2012) Challenges in blood pressure self-measurement. International Journal of Telemedicine and Applications, 2012, 2.
  • Wilson, I. B., Rogers, W. H., Chang, H., and Safran, D. G. (2005) Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Journal of General Internal Medicine, 20, 715–720.
  • Xie, B., Dilts, D. M., and Shor, M. (2006) The physician–patient relationship: The impact of patient-obtained medical information. Health Economics, 15, 813–833.
  • Zhu, Z. (2012) Optimal Financing Structure Mechanism Design for Healthcare Insurance. Ph.D. thesis, Purdue University.
  • Zweifel, P., and Manning, W. G. (2000) Moral hazard and consumer incentives in health care. In Handbook of Health Economics, volume 1 (pp. 409–459). Elsevier, Netherlands.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.